Trial 1

Trial Title Name of the research study

Principal Investigator(s) Lead researcher(s) name(s)

Institution / Affiliation University, clinic, or research body

Trial Phase (e.g., Phase I, II, III, observational, qualitative, etc.)

Trial Focus / Substance e.g., Psilocybin for depression, MDMA for PTSD, Ayahuasca, Ketamine, etc.

Therapeutic Approach PAT model used: e.g., IFS, somatic, CBT, traditional ceremony

Target Population e.g., Veterans, LGBTQ+, First Nations, treatment-resistant depression

Recruitment Status Open / Closed / Planned

Trial Location City, state, country, virtual/hybrid

Start and End Dates Timeline of the trial

Participant Criteria Inclusion/exclusion summary

Ethics Approval Details Committee, approval number (if applicable)

Funding Body / Sponsor Grant provider or sponsor (if applicable)

Contact for Collaboration Email / phone of lead or admin contact

Link to Official Trial Page ClinicalTrials.gov or institutional page

Any supporting Documentation